Patent 7611718 was granted and assigned to MedImmune on November, 2009 by the United States Patent and Trademark Office.
A method is provided for attenuating a cytomegalovirus comprising functionally disrupting an open reading frame of a Toledo genome region or its homolog and making chimeric CMV virus genomes.